Mostrar el registro sencillo del ítem

Artículo

dc.creatorCarrasco Carrasco, Carlos Jesúses
dc.creatorMontilla Ramos, Francisco Javieres
dc.creatorÁlvarez González, Eleuterioes
dc.creatorCalderón Montaño, José Manueles
dc.creatorLópez Lázaro, Migueles
dc.creatorGalindo del Pozo, Agustínes
dc.date.accessioned2022-08-31T16:36:03Z
dc.date.available2022-08-31T16:36:03Z
dc.date.issued2022
dc.identifier.citationCarrasco Carrasco, C.J., Montilla Ramos, F.J., Álvarez González, E., Calderón Montaño, J.M., López Lázaro, M. y Galindo del Pozo, A. (2022). Chirality influence on the cytotoxic properties of anionic chiral bis(N-heterocyclic carbene)silver complexes. Journal of Inorganic Biochemistry, 235, 111924.
dc.identifier.issn0162-0134es
dc.identifier.issn1873-3344es
dc.identifier.urihttps://hdl.handle.net/11441/136581
dc.description.abstractComplexes Na3[Ag(NHCR)2], 2a-e and 2b’-c’, where NHCR is a N-heterocyclic carbene of the 2,2′-(1H-2λ3,3λ4-imidazole-1,3-diyl)dicarboxylate type, were prepared by treatment of compounds HLR, 1a-e and 1b’-c’ (2-(1-(carboxyalkyl)-1H-imidazol-3-ium-3-yl)carboxylate), with silver oxide in the presence of aqueous sodium hydroxide. They were characterized by analytical, spectroscopic (infrared, IR, 1H and 13C nuclear magnetic resonance, NMR, and circular dichroism) and X-ray methods (2a). In the solid state, the anionic part of complex 2a, [Ag(NHCH)2]3−, shows a linear disposition of Ccarbene-Ag-Ccarbene atoms and an eclipsed conformation of the two NHC ligands. The proposed bis(NHC) nature of the silver complexes was maintained in solution according to NMR and density functional theory (DFT) calculations. The cytotoxic activity of compounds 2 was evaluated against four cancer cell lines and one non-cancerous cell line and several structure-activity correlations were found for these complexes. For instance, the activity decreased when the bulkiness of the R alkyl group in Na3[Ag(NHCR)2] increased. More interesting is the detected chirality-anticancer relationship, where complexes Na3[Ag{(S,S)-NHCR}2] (R = Me, 2b; iPr, 2c) showed better anticancer activity than those of their enantiomeric derivatives Na3[Ag{(R,R)-NHCR}2] (R = Me, 2b’; iPr, 2c’).es
dc.description.sponsorshipMinisterio de Ciencia e Innovación PGC2018-093443-B-I00es
dc.description.sponsorshipUniversidad de Sevilla VIPPIT-2021-I.5es
dc.formatapplication/pdfes
dc.format.extent9 p.es
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofJournal of Inorganic Biochemistry, 235, 111924.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnticanceres
dc.subjectChirales
dc.subjectNHC-dicarboxylatees
dc.subjectSilveres
dc.subjectX-rayes
dc.titleChirality influence on the cytotoxic properties of anionic chiral bis(N-heterocyclic carbene)silver complexeses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Inorgánicaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacologíaes
dc.relation.projectIDPGC2018-093443-B-I00es
dc.relation.projectIDVIPPIT-2021-I.5es
dc.relation.publisherversionhttps://doi.org/10.1016/j.jinorgbio.2022.111924es
dc.identifier.doi10.1016/j.jinorgbio.2022.111924es
dc.journaltitleJournal of Inorganic Biochemistryes
dc.publication.volumen235es
dc.publication.initialPage111924es
dc.contributor.funderMinisterio de Ciencia e Innovación (MICIN). Españaes
dc.contributor.funderUniversidad de Sevillaes
dc.description.awardwinningPremio Mensual Publicación Científica Destacada de la US. Facultad de Química

FicherosTamañoFormatoVerDescripción
Chirality influence.pdf1.041MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional